Burnham & Co’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.8K Hold
400
– – 0.03% 127
2026
Q2
$43.7K Hold
400
– – 0.04% 125
2026
Q1
$41.6K Buy
+400
New +$42.6K 0.04% 115

Other funds holding PPH

Burnham & Co's PPH Position: Q3 2026 in Review

Burnham & Co held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2026 at 400 shares worth $43.8K. The position accounts for 0.03% of the portfolio, ranked #127.

Burnham & Co first reported a position in PPH in Q1 2026 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Burnham & Co held 400 shares of VanEck Pharmaceutical ETF worth $43.8K as of Q3 2026.
  • Burnham & Co left its VanEck Pharmaceutical ETF share count unchanged in Q3 2026.
  • VanEck Pharmaceutical ETF made up 0.03% of Burnham & Co's portfolio in Q3 2026, its #127 holding.
  • Burnham & Co first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 3 quarters since.
  • 155 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.